Cookies help us run our site more efficiently.

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information or to customize your cookie preferences.

CDC urges covid, flu shots, but public interest is flagging

News Feed
Thursday, September 26, 2024

Hi, I’m Fenit Nirappil a public health reporter for The Post, and I for one am eager to get a coronavirus shot this fall after covid ruined Christmases past. What covid or other public health stories aren’t getting enough attention? Send me your thoughts at fenit.nirappil@washpost.comSubscribe for unlimited access to The PostYou can cancel anytime.SubscribeToday’s edition: Congress passed legislation to avert a government shutdown. Two Senate Democrats are teaming up to tackle the unregulated hemp market. But first …New survey finds tepid interest in covid, flu, RSV shotsSurvey data shows few U.S. adults are concerned about respiratory viruses or interested in getting shots. (Astrid Riecken/The Washington Post)Federal health officials are urging Americans to get vaccinated ahead of the respiratory virus season as new survey data shows tepid interest in getting shots.Mandy Cohen, director of the Centers for Disease Control and Prevention, said the agency anticipates 800,000 flu, covid and respiratory syncytial virus (RSV) hospitalizations in the coming months, on par with last year.“These vaccines can cut the risk of hospitalization in half,” Cohen said at a Wednesday news conference where she received a flu shot on camera.But results released Wednesday from an annual National Foundation for Infectious Diseases survey reveals that relatively few U.S. adults are concerned about respiratory viruses (less than 1 in 5) or interested in getting shots. The survey was conducted in early August.55 percent definitely or probably will get a flu shot, 34 percent definitely or probably will not.40 percent definitely or probably will get the updated coronavirus vaccine, while 45 percent definitely or probably will not.38 percent of eligible older adults definitely or probably will get an RSV vaccine, while 25 percent definitely or probably will not.The percentages of adults who say they will definitely or probably get flu and coronavirus shots mirror last year’s survey results. The shares that definitely or probably won’t slightly increased.Just because someone says they’ll get a shot doesn’t mean they’ll actually follow through. Last year, 45 percent of adults got the flu shot.New CDC estimates show that 23 percent of adults and 38 percent of people 65 and older received last year’s coronavirus vaccine.Strikingly, just 31 percent of medical professionals received a dose of the 2023 vaccine. Cohen said health-care workers can boost vaccination rates by promoting the shots when seeing patients.The numbers reflect public health officials’ increasingly lonely fight to persuade Americans to get vaccinated. Today, fewer high-profile figures step up to lead by example, which they did when coronavirus vaccines debuted.Last year, President Joe Biden and Vice President Kamala Harris urged Americans to get a new covid vaccine, but they haven’t done so this fall. Their aides did not return repeated requests for comment. When Biden got covid this summer, the White House declined to say whether he was up-to-date on his vaccinations and had received a second dose of the 2023-2024 vaccine.Covid does not hospitalize or kill as many people as it used to thanks to immunity built up from vaccination and prior infections, but it can still cause severe disease, especially in older and immunocompromised adults. And it can also cause lasting debilitating symptoms known as long covid in otherwise healthy children and adults, though that has become less common.Concerns about side effects ranked as the top reason survey respondents cited for not planning to get vaccinated, the National Foundation for Infectious Diseases said.The CDC counters that covid, flu and RSV pose a far greater danger than the vaccines.“The benefit of the vaccine is far greater than its risk, and we know that vaccines prevent really severe complications,” said Demetre Daskalakis, director of the CDC’s National Center for Immunization and Respiratory Diseases.Reed Tuckson, board chair of the Coalition For Trust In Health & Science, blamed misinformation for erosions in vaccine confidence.“We are flooded and bombarded with social media and other forms of public conversation with just plain old facts that are wrong,” Tuckson said. “They are not facts – they are misrepresentations.”On the HillCongress passes bill to avert government shutdown, setting up December fightCongress approved legislation Wednesday to extend federal funding for three months, staving off a looming government shutdown ahead of November’s elections, The Post’s Jacob Bogage reports.The bill, which passed both the House and Senate with wide bipartisan support, extends federal finances to Dec. 20. It heads to Biden’s desk with time to spare before government funds would expire on Monday.Yes, but: The temporary solution sets the stage for a new tussle during the lame-duck, end-of-year session to pass annual funding bills for the rest of the 2025 fiscal year, with several high-profile issues still unresolved. For example, the Department of Veterans Affairs needs an additional $12 billion to provide care for military service members sickened by toxic burn pits.In other news from Capitol Hill ...The Senate voted unanimously on Wednesday to hold Steward Health Care CEO Ralph de la Torre in contempt, asking the Justice Department to pursue criminal charges against the hospital executive for failing to comply with a congressional subpoena, our colleague Dan Diamond reports.Catch up quick: Steward, a for-profit company that owns about two dozen hospitals nationwide, is embroiled in bankruptcy proceedings and seeking to sell its facilities. Community leaders and health workers have accused its executives of taking extravagant paydays while its hospitals struggled to stay afloat. The Justice Department is also investigating Steward over fraud allegations.In July, the Senate Health, Education, Labor and Pensions Committee launched a bipartisan inquiry into Steward’s financial practices, issuing a subpoena to compel de la Torre’s testimony. However, he skipped the hearing earlier this month.De la Torre’s attorney, Alexander J. Merton, has defended his client’s refusal to testify, labeling the proceedings as “a pseudo-criminal proceeding with the goal of convicting Dr. de la Torre in a court of public opinion.”From our notebookSenate Democrats unveil bill to rein in hemp marketOregon’s U.S. senators introduced a bill to establish federal restrictions on hemp products, which have proliferated since Congress legalized the plant in 2018, our colleague David Ovalle writes.The Cannabinoid Safety and Regulation Act, sponsored by Democratic Sens. Ron Wyden and Jeff Merkley, would bar anyone under 21 from buying edibles, vapes and other products made from hemp-derived compounds such as delta-8 THC.The bill, which is supported by numerous hemp industry associations, would also require safety testing and allow the Food and Drug Administration to recall or ban products found with dangerous chemicals or additives.Agency alert10th listeria death tied to Boar’s Head deli meatA New York resident has died amid a nationwide listeria outbreak tied to Boar’s Head deli meat, the CDC announced, bringing the death toll to 10 in the largest outbreak of the foodborne illness since 2011, per The Post’s Rachel Roubein and Joe Heim.The CDC noted that illnesses have started to decline, but it also confirmed two new hospitalizations linked to the outbreak, with a total of 59 individuals hospitalized across 19 states since late May. The agency said the number of sick people is probably higher than the official case count.Key context: Boar’s Head identified the production process for liverwurst at its plant in Jarratt, Va., as the source of contamination. Last week, the company announced it would indefinitely close the facility and permanently discontinue liverwurst production.The plant was repeatedly cited for health and safety violations for nearly two years before the deadly outbreak.Meanwhile, across the agencies …Enrollees in the Federal Employees Health Benefits program will see expanded coverage for fertility services from more insurers in 2025, including two nationwide plans that will offer $25,000 in benefits for in vitro fertilization, the Office of Personnel Management announced.A federal judge ordered the Environmental Protection Agency to further regulate fluoride in drinking water, citing a U.S. government report that determined “with moderate confidence” that there is a link between higher exposure and lower IQ in young people.In other health newsNew this a.m.: Suicide remained the 11th leading cause of death across all age groups in the United States in 2022, unchanged from the prior year. Firearms were the most common method among both males and females, according to final data from the CDC’s National Center for Health Statistics.On the move: The Association for Accessible Medicines has tapped John A. Murphy as its new president and chief executive officer, starting in October. Murphy most recently served as the chief policy officer at the Biotechnology Innovation Organization.On the move: The American Academy of Family Physicians has named Jen Brull as its new president. Brull, a Colorado family physician, currently serves as vice president of clinical engagement for Aledade, which manages the nation’s largest network of independent primary care.Health readsSugar rushThanks for reading! Not a subscriber? Sign up here.

The CDC anticipates 800,000 flu, covid and respiratory syncytial virus hospitalizations in the coming months, on par with last year.

Hi, I’m Fenit Nirappil a public health reporter for The Post, and I for one am eager to get a coronavirus shot this fall after covid ruined Christmases past. What covid or other public health stories aren’t getting enough attention? Send me your thoughts at fenit.nirappil@washpost.com

Subscribe for unlimited access to The Post

You can cancel anytime.

Subscribe

Today’s edition: Congress passed legislation to avert a government shutdown. Two Senate Democrats are teaming up to tackle the unregulated hemp market. But first …

New survey finds tepid interest in covid, flu, RSV shots

Survey data shows few U.S. adults are concerned about respiratory viruses or interested in getting shots. (Astrid Riecken/The Washington Post)

Federal health officials are urging Americans to get vaccinated ahead of the respiratory virus season as new survey data shows tepid interest in getting shots.

Mandy Cohen, director of the Centers for Disease Control and Prevention, said the agency anticipates 800,000 flu, covid and respiratory syncytial virus (RSV) hospitalizations in the coming months, on par with last year.

“These vaccines can cut the risk of hospitalization in half,” Cohen said at a Wednesday news conference where she received a flu shot on camera.

But results released Wednesday from an annual National Foundation for Infectious Diseases survey reveals that relatively few U.S. adults are concerned about respiratory viruses (less than 1 in 5) or interested in getting shots. The survey was conducted in early August.

  • 55 percent definitely or probably will get a flu shot, 34 percent definitely or probably will not.
  • 40 percent definitely or probably will get the updated coronavirus vaccine, while 45 percent definitely or probably will not.
  • 38 percent of eligible older adults definitely or probably will get an RSV vaccine, while 25 percent definitely or probably will not.

The percentages of adults who say they will definitely or probably get flu and coronavirus shots mirror last year’s survey results. The shares that definitely or probably won’t slightly increased.

Just because someone says they’ll get a shot doesn’t mean they’ll actually follow through. Last year, 45 percent of adults got the flu shot.

New CDC estimates show that 23 percent of adults and 38 percent of people 65 and older received last year’s coronavirus vaccine.

Strikingly, just 31 percent of medical professionals received a dose of the 2023 vaccine. Cohen said health-care workers can boost vaccination rates by promoting the shots when seeing patients.

The numbers reflect public health officials’ increasingly lonely fight to persuade Americans to get vaccinated. Today, fewer high-profile figures step up to lead by example, which they did when coronavirus vaccines debuted.

Last year, President Joe Biden and Vice President Kamala Harris urged Americans to get a new covid vaccine, but they haven’t done so this fall. Their aides did not return repeated requests for comment. When Biden got covid this summer, the White House declined to say whether he was up-to-date on his vaccinations and had received a second dose of the 2023-2024 vaccine.

Covid does not hospitalize or kill as many people as it used to thanks to immunity built up from vaccination and prior infections, but it can still cause severe disease, especially in older and immunocompromised adults. And it can also cause lasting debilitating symptoms known as long covid in otherwise healthy children and adults, though that has become less common.

Concerns about side effects ranked as the top reason survey respondents cited for not planning to get vaccinated, the National Foundation for Infectious Diseases said.

The CDC counters that covid, flu and RSV pose a far greater danger than the vaccines.

“The benefit of the vaccine is far greater than its risk, and we know that vaccines prevent really severe complications,” said Demetre Daskalakis, director of the CDC’s National Center for Immunization and Respiratory Diseases.

Reed Tuckson, board chair of the Coalition For Trust In Health & Science, blamed misinformation for erosions in vaccine confidence.

“We are flooded and bombarded with social media and other forms of public conversation with just plain old facts that are wrong,” Tuckson said. “They are not facts – they are misrepresentations.”

On the Hill

Congress passes bill to avert government shutdown, setting up December fight

Congress approved legislation Wednesday to extend federal funding for three months, staving off a looming government shutdown ahead of November’s elections, The Post’s Jacob Bogage reports.

The bill, which passed both the House and Senate with wide bipartisan support, extends federal finances to Dec. 20. It heads to Biden’s desk with time to spare before government funds would expire on Monday.

Yes, but: The temporary solution sets the stage for a new tussle during the lame-duck, end-of-year session to pass annual funding bills for the rest of the 2025 fiscal year, with several high-profile issues still unresolved. For example, the Department of Veterans Affairs needs an additional $12 billion to provide care for military service members sickened by toxic burn pits.

In other news from Capitol Hill ...

The Senate voted unanimously on Wednesday to hold Steward Health Care CEO Ralph de la Torre in contempt, asking the Justice Department to pursue criminal charges against the hospital executive for failing to comply with a congressional subpoena, our colleague Dan Diamond reports.

Catch up quick: Steward, a for-profit company that owns about two dozen hospitals nationwide, is embroiled in bankruptcy proceedings and seeking to sell its facilities. Community leaders and health workers have accused its executives of taking extravagant paydays while its hospitals struggled to stay afloat. The Justice Department is also investigating Steward over fraud allegations.

In July, the Senate Health, Education, Labor and Pensions Committee launched a bipartisan inquiry into Steward’s financial practices, issuing a subpoena to compel de la Torre’s testimony. However, he skipped the hearing earlier this month.

De la Torre’s attorney, Alexander J. Merton, has defended his client’s refusal to testify, labeling the proceedings as “a pseudo-criminal proceeding with the goal of convicting Dr. de la Torre in a court of public opinion.”

From our notebook

Senate Democrats unveil bill to rein in hemp market

Oregon’s U.S. senators introduced a bill to establish federal restrictions on hemp products, which have proliferated since Congress legalized the plant in 2018, our colleague David Ovalle writes.

The Cannabinoid Safety and Regulation Act, sponsored by Democratic Sens. Ron Wyden and Jeff Merkley, would bar anyone under 21 from buying edibles, vapes and other products made from hemp-derived compounds such as delta-8 THC.

The bill, which is supported by numerous hemp industry associations, would also require safety testing and allow the Food and Drug Administration to recall or ban products found with dangerous chemicals or additives.

Agency alert

10th listeria death tied to Boar’s Head deli meat

A New York resident has died amid a nationwide listeria outbreak tied to Boar’s Head deli meat, the CDC announced, bringing the death toll to 10 in the largest outbreak of the foodborne illness since 2011, per The Post’s Rachel Roubein and Joe Heim.

The CDC noted that illnesses have started to decline, but it also confirmed two new hospitalizations linked to the outbreak, with a total of 59 individuals hospitalized across 19 states since late May. The agency said the number of sick people is probably higher than the official case count.

Key context: Boar’s Head identified the production process for liverwurst at its plant in Jarratt, Va., as the source of contamination. Last week, the company announced it would indefinitely close the facility and permanently discontinue liverwurst production.

The plant was repeatedly cited for health and safety violations for nearly two years before the deadly outbreak.

Meanwhile, across the agencies …

Enrollees in the Federal Employees Health Benefits program will see expanded coverage for fertility services from more insurers in 2025, including two nationwide plans that will offer $25,000 in benefits for in vitro fertilization, the Office of Personnel Management announced.

A federal judge ordered the Environmental Protection Agency to further regulate fluoride in drinking water, citing a U.S. government report that determined “with moderate confidence” that there is a link between higher exposure and lower IQ in young people.

In other health news

  • New this a.m.: Suicide remained the 11th leading cause of death across all age groups in the United States in 2022, unchanged from the prior year. Firearms were the most common method among both males and females, according to final data from the CDC’s National Center for Health Statistics.
  • On the move: The Association for Accessible Medicines has tapped John A. Murphy as its new president and chief executive officer, starting in October. Murphy most recently served as the chief policy officer at the Biotechnology Innovation Organization.
  • On the move: The American Academy of Family Physicians has named Jen Brull as its new president. Brull, a Colorado family physician, currently serves as vice president of clinical engagement for Aledade, which manages the nation’s largest network of independent primary care.

Health reads

Sugar rush

Thanks for reading! Not a subscriber? Sign up here.

Read the full story here.
Photos courtesy of

Forever Chemicals' Might Triple Teens' Risk Of Fatty Liver Disease

By Dennis Thompson HealthDay ReporterTHURSDAY, Jan. 8, 2026 (HealthDay News) — PFAS “forever chemicals” might nearly triple a young person’s risk...

By Dennis Thompson HealthDay ReporterTHURSDAY, Jan. 8, 2026 (HealthDay News) — PFAS “forever chemicals” might nearly triple a young person’s risk of developing fatty liver disease, a new study says.Each doubling in blood levels of the PFAS chemical perfluorooctanoic acid is linked to 2.7 times the odds of fatty liver disease among teenagers, according to findings published in the January issue of the journal Environmental Research.Fatty liver disease — also known as metabolic dysfunction-associated steatotic liver disease (MASLD) — occurs when fat builds up in the organ, leading to inflammation, scarring and increased risk of cancer.About 10% of all children, and up to 40% of children with obesity, have fatty liver disease, researchers said in background notes.“MASLD can progress silently for years before causing serious health problems,” said senior researcher Dr. Lida Chatzi, a professor of population and public health sciences and pediatrics at the Keck School of Medicine of USC in Los Angeles.“When liver fat starts accumulating in adolescence, it may set the stage for a lifetime of metabolic and liver health challenges,” Chatzi added in a news release. “If we reduce PFAS exposure early, we may help prevent liver disease later. That’s a powerful public health opportunity.”Per- and polyfluoroalkyl substances (PFAS) are called “forever chemicals” because they combine carbon and fluorine molecules, one of the strongest chemical bonds possible. This makes PFAS removal and breakdown very difficult.PFAS compounds have been used in consumer products since the 1940s, including fire extinguishing foam, nonstick cookware, food wrappers, stain-resistant furniture and waterproof clothing.More than 99% of Americans have measurable PFAS in their blood, and at least one PFAS chemical is present in roughly half of U.S. drinking water supplies, researchers said.“Adolescents are particularly more vulnerable to the health effects of PFAS as it is a critical period of development and growth,” lead researcher Shiwen “Sherlock” Li, an assistant professor of public health sciences at the University of Hawaii, said in a news release.“In addition to liver disease, PFAS exposure has been associated with a range of adverse health outcomes, including several types of cancer,” Li said.For the new study, researchers examined data on 284 Southern California adolescents and young adults gathered as part of two prior USC studies.All of the participants already had a high risk of metabolic disease because their parents had type 2 diabetes or were overweight, researchers said.Their PFAS levels were measured through blood tests, and liver fat was assessed using MRI scans.Higher blood levels of two common PFAS — perfluorooctanoic acid (PFOA) and perfluoroheptanoic acid (PFHpA) — were linked to an increased risk of fatty liver disease.Results showed a young person’s risk was even higher if they smoked or carried a genetic variant known to influence liver fat.“These findings suggest that PFAS exposures, genetics and lifestyle factors work together to influence who has greater risk of developing MASLD as a function of your life stage,” researcher Max Aung, assistant professor of population and public health sciences at the Keck School of Medicine, said in a news release.“Understanding gene and environment interactions can help advance precision environmental health for MASLD,” he added.The study also showed that fatty liver disease became more common as teens grew older, adding to evidence that younger people might be more vulnerable to PFAS exposure, Chatzi said.“PFAS exposures not only disrupt liver biology but also translate into real liver disease risk in youth,” Chatzi said. “Adolescence seems to be a critical window of susceptibility, suggesting PFAS exposure may matter most when the liver is still developing.”The Environmental Working Group has more on PFAS.SOURCES: Keck School of Medicine of USC, news release, Jan. 6, 2026; Environmental Research, Jan. 1, 2026Copyright © 2026 HealthDay. All rights reserved.

China Announces Another New Trade Measure Against Japan as Tensions Rise

China has escalated its trade tensions with Japan by launching an investigation into imported dichlorosilane, a chemical gas used in making semiconductors

BEIJING (AP) — China escalated its trade tensions with Japan on Wednesday by launching an investigation into imported dichlorosilane, a chemical gas used in making semiconductors, a day after it imposed curbs on the export of so-called dual-use goods that could be used by Japan’s military.The Chinese Commerce Ministry said in a statement that it had launched the investigation following an application from the domestic industry showing the price of dichlorosilane imported from Japan had decreased 31% between 2022 and 2024.“The dumping of imported products from Japan has damaged the production and operation of our domestic industry,” the ministry said.The measure comes a day after Beijing banned exports to Japan of dual-use goods that can have military applications.Beijing has been showing mounting displeasure with Tokyo after new Japanese Prime Minister Sanae Takaichi suggested late last year that her nation's military could intervene if China were to take action against Taiwan — an island democracy that Beijing considers its own territory.Tensions were stoked again on Tuesday when Japanese lawmaker Hei Seki, who last year was sanctioned by China for “spreading fallacies” about Taiwan and other disputed territories, visited Taiwan and called it an independent country. Also known as Yo Kitano, he has been banned from entering China. He told reporters that his arrival in Taiwan demonstrated the two are “different countries.”“I came to Taiwan … to prove this point, and to tell the world that Taiwan is an independent country,” Hei Seki said, according to Taiwan’s Central News Agency.“The nasty words of a petty villain like him are not worth commenting on,” Chinese Foreign Ministry spokesperson Mao Ning retorted when asked about his comment. Fears of a rare earths curb Masaaki Kanai, head of Asia Oceanian Affairs at Japan's Foreign Ministry, urged China to scrap the trade curbs, saying a measure exclusively targeting Japan that deviates from international practice is unacceptable. Japan, however, has yet to announce any retaliatory measures.As the two countries feuded, speculation rose that China might target rare earths exports to Japan, in a move similar to the rounds of critical minerals export restrictions it has imposed as part of its trade war with the United States.China controls most of the global production of heavy rare earths, used for making powerful, heat-resistance magnets used in industries such as defense and electric vehicles.While the Commerce Ministry did not mention any new rare earths curbs, the official newspaper China Daily, seen as a government mouthpiece, quoted anonymous sources saying Beijing was considering tightening exports of certain rare earths to Japan. That report could not be independently confirmed. Improved South Korean ties contrast with Japan row As Beijing spars with Tokyo, it has made a point of courting a different East Asian power — South Korea.On Wednesday, South Korean President Lee Jae Myung wrapped up a four-day trip to China – his first since taking office in June. Lee and Chinese President Xi Jinping oversaw the signing of cooperation agreements in areas such as technology, trade, transportation and environmental protection.As if to illustrate a contrast with the China-Japan trade frictions, Lee joined two business events at which major South Korean and Chinese companies pledged to collaborate.The two sides signed 24 export contracts worth a combined $44 million, according to South Korea’s Ministry of Trade, Industry and Resources. During Lee’s visit, Chinese media also reported that South Korea overtook Japan as the leading destination for outbound flights from China’s mainland over the New Year’s holiday.China has been discouraging travel to Japan, saying Japanese leaders’ comments on Taiwan have created “significant risks to the personal safety and lives of Chinese citizens in Japan.”Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.Photos You Should See – December 2025

Pesticide industry ‘immunity shield’ stripped from US appropriations bill

Democrats and the Make America Healthy Again movement pushed back on the rider in a funding bill led by BayerIn a setback for the pesticide industry, Democrats have succeeded in removing a rider from a congressional appropriations bill that would have helped protect pesticide makers from being sued and could have hindered state efforts to warn about pesticide risks.Chellie Pingree, a Democratic representative from Maine and ranking member of the House appropriations interior, environment, and related agencies subcommittee, said Monday that the controversial measure pushed by the agrochemical giant Bayer and industry allies has been stripped from the 2026 funding bill. Continue reading...

In a setback for the pesticide industry, Democrats have succeeded in removing a rider from a congressional appropriations bill that would have helped protect pesticide makers from being sued and could have hindered state efforts to warn about pesticide risks.Chellie Pingree, a Democratic representative from Maine and ranking member of the House appropriations interior, environment, and related agencies subcommittee, said Monday that the controversial measure pushed by the agrochemical giant Bayer and industry allies has been stripped from the 2026 funding bill.The move is final, as Senate Republican leaders have agreed not to revisit the issue, Pingree said.“I just drew a line in the sand and said this cannot stay in the bill,” Pingree told the Guardian. “There has been intensive lobbying by Bayer. This has been quite a hard fight.”The now-deleted language was part of a larger legislative effort that critics say is aimed at limiting litigation against pesticide industry leader Bayer, which sells the widely used Roundup herbicides.An industry alliance set up by Bayer has been pushing for both state and federal laws that would make it harder for consumers to sue over pesticide risks to human health and has successfully lobbied for the passing of such laws in Georgia and North Dakota so far.The specific proposed language added to the appropriations bill blocked federal funds from being used to “issue or adopt any guidance or any policy, take any regulatory action, or approve any labeling or change to such labeling” inconsistent with the conclusion of an Environmental Protection Agency (EPA) human health assessment.Critics said the language would have impeded states and local governments from warning about risks of pesticides even in the face of new scientific findings about health harms if such warnings were not consistent with outdated EPA assessments. The EPA itself would not be able to update warnings without finalizing a new assessment, the critics said.And because of the limits on warnings, critics of the rider said, consumers would have found it difficult, if not impossible, to sue pesticide makers for failing to warn them of health risks if the EPA assessments do not support such warnings.“This provision would have handed pesticide manufacturers exactly what they’ve been lobbying for: federal preemption that stops state and local governments from restricting the use of harmful, cancer-causing chemicals, adding health warnings, or holding companies accountable in court when people are harmed,” Pingree said in a statement. “It would have meant that only the federal government gets a say – even though we know federal reviews can take years, and are often subject to intense industry pressure.”Pingree tried but failed to overturn the language in a July appropriations committee hearing.Bayer, the key backer of the legislative efforts, has been struggling for years to put an end to thousands of lawsuits filed by people who allege they developed cancer from their use of Roundup and other glyphosate-based weed killers sold by Bayer. The company inherited the litigation when it bought Monsanto in 2018 and has paid out billions of dollars in settlements and jury verdicts but still faces several thousand ongoing lawsuits. Bayer maintains its glyphosate-based herbicides do not cause cancer and are safe when used as directed.When asked for comment on Monday, Bayer said that no company should have “blanket immunity” and it disputed that the appropriations bill language would have prevented anyone from suing pesticide manufacturers. The company said it supports state and federal legislation “because the future of American farming depends on reliable science-based regulation of important crop protection products – determined safe for use by the EPA”.The company additionally states on its website that without “legislative certainty”, lawsuits over its glyphosate-based Roundup and other weed killers can impact its research and product development and other “important investments”.Pingree said her efforts were aided by members of the Make America Healthy Again (Maha) movement who have spent the last few months meeting with congressional members and their staffers on this issue. She said her team reached out to Maha leadership in the last few days to pressure Republican lawmakers.“This is the first time that we’ve had a fairly significant advocacy group working on the Republican side,” she said.Last week, Zen Honeycutt, a Maha leader and founder of the group Moms Across America, posted a “call to action”, urging members to demand elected officials “Stop the Pesticide Immunity Shield”.“A lot of people helped make this happen,” Honeycutt said. “Many health advocates have been fervently expressing their requests to keep chemical companies accountable for safety … We are delighted that our elected officials listened to so many Americans who spoke up and are restoring trust in the American political system.”Pingree said the issue is not dead. Bayer has “made this a high priority”, and she expects to see continued efforts to get industry friendly language inserted into legislation, including into the new Farm Bill.“I don’t think this is over,” she said.This story is co-published with the New Lede, a journalism project of the Environmental Working Group

Forever Chemicals' Common in Cosmetics, but FDA Says Safety Data Are Scant

By Deanna Neff HealthDay ReporterSATURDAY, Jan. 3, 2026 (HealthDay News) — Federal regulators have released a mandated report regarding the...

By Deanna Neff HealthDay ReporterSATURDAY, Jan. 3, 2026 (HealthDay News) — Federal regulators have released a mandated report regarding the presence of "forever chemicals" in makeup and skincare products. Forever chemicals — known as perfluoroalkyl and polyfluoroalkyl substances or PFAS — are manmade chemicals that don't break down and have built up in people’s bodies and the environment. They are sometimes added to beauty products intentionally, and sometimes they are contaminants. While the findings confirm that PFAS are widely used in the beauty industry, the U.S. Food and Drug Administration (FDA) admitted it lacks enough scientific evidence to determine if they are truly safe for consumers.The new report reveals that 51 forever chemicals — are used in 1,744 cosmetic formulations. These synthetic chemicals are favored by manufacturers because they make products waterproof, increase their durability and improve texture.FDA scientists focused their review on the 25 most frequently used PFAS, which account for roughly 96% of these chemicals found in beauty products. The results were largely unclear. While five were deemed to have low safety concerns, one was flagged for potential health risks, and safety of the rest could not be confirmed.FDA Commissioner Dr. Marty Makary expressed concern over the difficulty in accessing private research. “Our scientists found that toxicological data for most PFAS are incomplete or unavailable, leaving significant uncertainty about consumer safety,” Makary said in a news release, adding that “this lack of reliable data demands further research.”Despite growing concerns about their potential toxicity, no federal laws specifically ban their use in cosmetics.The FDA report focuses on chemicals that are added to products on purpose, rather than those that might show up as accidental contaminants. Moving forward, FDA plans to work closely with the U.S. Centers for Disease Control and Prevention (CDC) and the Environmental Protection Agency (EPA) to update and strengthen recommendations on PFAS across the retail and food supply chain, Makary said. The agency has vowed to devote more resources to monitoring these chemicals and will take enforcement action if specific products are proven to be dangerous.The U.S. Food and Drug Administration provides updates and consumer guidance on the use of PFAS in cosmetics.SOURCE: U.S. Food and Drug Administration, news release, Dec. 29, 2025Copyright © 2026 HealthDay. All rights reserved.

Suggested Viewing

Join us to forge
a sustainable future

Our team is always growing.
Become a partner, volunteer, sponsor, or intern today.
Let us know how you would like to get involved!

CONTACT US

sign up for our mailing list to stay informed on the latest films and environmental headlines.

Subscribers receive a free day pass for streaming Cinema Verde.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.